OrbusNeich Honored at Industry Cares 2024 with ” Outstanding Caring Award” and “The Best CSV Award”

(Hong Kong, October 2, 2024) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, has been awarded the “Outstanding Caring Award ” and ” The Best CSV Award ” in the SME category of the Industry Cares Recognition Scheme organized by the Federation of Hong Kong Industries. This award recognizes the Group’s commitment to corporate social responsibility by integrating corporate citizenship principles into its operational strategies and management practices. It actively gives back to society to create shared value for stakeholders.

OrbusNeich believes that the health and development of the community are closely tied to the growth of the enterprise. Therefore, the company invests in creating shared value that benefits both the community and its business. The Group aligns its corporate resources with community needs through various initiatives. The three awarded projects exemplify this commitment through practical actions.

The Physician Education Program is a continuous exchange initiative designed to help medical professionals maintain their competence and learn about new and emerging areas in their field. Each year, the Group invites experienced physicians to share their knowledge with local physicians in Southeast Asia. The ASCENT (Annual Scientific Congress and Exchange for Next Generation InTerventionalists) is a tailored educational program that offers the next generation of interventionalists learning opportunities with senior physicians who have diverse expertise. Its goal is to enhance knowledge, refine skills, and cultivate expertise in both routine and complex procedural approaches. The Group’s Community Wellbeing Program includes company-sponsored initiatives and volunteer activities, such as charity runs and organized volunteer days. This program integrates employee participation with social responsibility, engaging more people in public welfare and contributing to a healthier future.

The Hong Kong Federation of Industries has held the Industry Cares Recognition Scheme since 2013. This year’s award ceremony took place on September 26, 2024, with Mr. Chris Sun, Secretary for Labour and Welfare of the Hong Kong SAR Government, serving as the guest of honor to recognize companies that bring positive benefits to society.

The Industry Cares Recognition Scheme 2024 award presentation ceremony was held on September 26, where Ms. Eva Chan, Director of Human Resources (middle), received the award on behalf of OrbusNeich.

－ End －

About OrbusNeich Medical Group Holdings Limited
OrbusNeich is a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, OrbusNeich sells its products in more than 70 countries and regions worldwide. It is also actively expanding into neuro vascular intervention and structural heart disease. As of June 30, 2024, OrbusNeich has more than 230 granted patents and published patent applications worldwide. Its in-house R&D team has more than two decades of product development experience and has developed world-leading proprietary technologies.

For more information, please visit the Group’s official website: https://orbusneich.com/.